Cargando…

Codelivery of thioridazine and doxorubicin using nanoparticles for effective breast cancer therapy

Cancer chemotherapy can benefit from the combination of different anticancer drugs. Here, we prepared doxorubicin (Dox)- and thioridazine (Thio)-coloaded methoxy poly(ethylene glycol)-poly(l-lactic acid) (MPEG-PLA) nanoparticles (NPs) for breast cancer therapy. These NPs have an average particle siz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Xun, Zou, Bingwen, Luo, Li, Zhong, Chuanhong, Zhang, Peilan, Cheng, Hao, Guo, Yanfang, Gou, Maling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019472/ https://www.ncbi.nlm.nih.gov/pubmed/27660446 http://dx.doi.org/10.2147/IJN.S104635

Ejemplares similares

Efficient intravesical therapy of bladder cancer with cationic doxorubicin nanoassemblies
por: Jin, Xun, et al.
Publicado: (2016)

Dual Targeted Nanoparticles for the Codelivery of Doxorubicin and siRNA Cocktails to Overcome Ovarian Cancer Stem Cells
por: Chen, Li, et al.
Publicado: (2023)

Codelivery of doxorubicin and curcumin with lipid nanoparticles results in improved efficacy of chemotherapy in liver cancer
por: Zhao, Xiaojing, et al.
Publicado: (2014)

Functionalized Large-Pore Mesoporous Silica Microparticles for Gefitinib and Doxorubicin Codelivery
por: Li, Yan, et al.
Publicado: (2019)

Docetaxel and Doxorubicin Codelivery by Nanocarriers for Synergistic Treatment of Prostate Cancer
por: Li, Ke, et al.
Publicado: (2019)

Enhanced apoptosis of ovarian cancer cells via nanocarrier-mediated codelivery of siRNA and doxorubicin
por: Zou, Seyin, et al.
Publicado: (2012)

Effect of Thioridazine on Erythrocytes
por: Lang, Elisabeth, et al.
Publicado: (2013)

Self‐Stabilized Hyaluronate Nanogel for Intracellular Codelivery of Doxorubicin and Cisplatin to Osteosarcoma
por: Zhang, Yi, et al.
Publicado: (2018)

Self‐Stabilized Hyaluronate Nanogel for Intracellular Codelivery of Doxorubicin and Cisplatin to Osteosarcoma
por: Zhang, Yi, et al.
Publicado: (2018)

Codelivery of doxorubicin and triptolide with reduction-sensitive lipid–polymer hybrid nanoparticles for in vitro and in vivo synergistic cancer treatment
por: Wu, Bo, et al.
Publicado: (2017)

Self-Assembling pH-Responsive Nanoparticle Platform Based on Pectin–Doxorubicin Conjugates for Codelivery of Anticancer Drugs
por: Tao, Yinghua, et al.
Publicado: (2021)

Dual-Functional Peptide Driven Liposome Codelivery System for Efficient Treatment of Doxorubicin-Resistant Breast Cancer
por: Ahmed, Kamel S, et al.
Publicado: (2021)

Transferrin-modified nanostructured lipid carriers as multifunctional nanomedicine for codelivery of DNA and doxorubicin
por: Han, Yiqun, et al.
Publicado: (2014)

Roles of dopamine receptors and their antagonist thioridazine in hepatoma metastasis
por: Lu, Meiling, et al.
Publicado: (2015)

A Modular Coassembly Approach to All-In-One Multifunctional Nanoplatform for Synergistic Codelivery of Doxorubicin and Curcumin
por: Yang, Muyang, et al.
Publicado: (2018)

Codelivery of doxorubicin and MDR1-siRNA by mesoporous silica nanoparticles-polymerpolyethylenimine to improve oral squamous carcinoma treatment
por: Wang, Dandan, et al.
Publicado: (2017)

Surface PEGylated Cancer Cell Membrane-Coated Nanoparticles for Codelivery of Curcumin and Doxorubicin for the Treatment of Multidrug Resistant Esophageal Carcinoma
por: Gao, Yi, et al.
Publicado: (2021)

Codelivery of Doxorubicin and Paclitaxel by Cross-Linked Multilamellar Liposome Enables Synergistic Antitumor Activity
por: Liu, Yarong, et al.
Publicado: (2014)

Dual-modified liposome codelivery of doxorubicin and vincristine improve targeting and therapeutic efficacy of glioma
por: Zhang, Yue, et al.
Publicado: (2017)

Smart Magnetic Nanocarriers for Codelivery of Nitric Oxide and Doxorubicin for Enhanced Apoptosis in Cancer Cells
por: Dutta, Bijaideep, et al.
Publicado: (2023)

Ultrasound‐guided percutaneous metal‐organic frameworks based codelivery system of doxorubicin/acetazolamide for hepatocellular carcinoma therapy
por: Jing, Ziwei, et al.
Publicado: (2021)

Codelivery of doxorubicin and elacridar to target both liver cancer cells and stem cells by polylactide-co-glycolide/d-alpha-tocopherol polyethylene glycol 1000 succinate nanoparticles
por: Chen, Dazhong, et al.
Publicado: (2018)

Selective Effects of Thioridazine on Self-Renewal of Basal-Like Breast Cancer Cells
por: Tegowski, Matthew, et al.
Publicado: (2019)

Combining thioridazine and loratadine for the treatment of gastrointestinal tumor
por: Chen, Tingting, et al.
Publicado: (2017)

Codelivery of Doxorubicin and MDR1-siRNA by Mesoporous Silica Nanoparticles-Polymerpolyethylenimine to Improve Oral Squamous Carcinoma Treatment [Corrigendum]
Publicado: (2021)

Enzyme-Enhanced Codelivery of Doxorubicin and Bcl-2 Inhibitor by Electrospun Nanofibers for Synergistic Inhibition of Prostate Cancer Recurrence
por: Liu, Zheng, et al.
Publicado: (2022)

A nanoselenium-coating biomimetic cytomembrane nanoplatform for mitochondrial targeted chemotherapy- and chemodynamic therapy through manganese and doxorubicin codelivery
por: Xiao, Jianmin, et al.
Publicado: (2021)

Codelivery of curcumin and doxorubicin by MPEG-PCL results in improved efficacy of systemically administered chemotherapy in mice with lung cancer
por: Wang, Bi-Lan, et al.
Publicado: (2013)

The Effect of Fluphenazine and Thioridazine on Toxoplasma gondii In Vivo
por: SARAEI, Mehrzad, et al.
Publicado: (2016)

Molecular mechanisms of thioridazine resistance in Staphylococcus aureus
por: Wassmann, Claes Søndergaard, et al.
Publicado: (2018)

Repurposing Thioridazine (TDZ) as an anti-inflammatory agent
por: Baig, Mirza S., et al.
Publicado: (2018)

Thioridazine as Chemotherapy for Mycobacterium avium Complex Diseases
por: Deshpande, Devyani, et al.
Publicado: (2016)

Aptamer-Mediated Codelivery of Doxorubicin and NF-κB Decoy Enhances Chemosensitivity of Pancreatic Tumor Cells
por: Porciani, David, et al.
Publicado: (2015)

Mitochondria-targeted and ultrasound-responsive nanoparticles for oxygen and nitric oxide codelivery to reverse immunosuppression and enhance sonodynamic therapy for immune activation
por: Ji, Changwei, et al.
Publicado: (2021)

Cascade targeting codelivery of ingenol-3-angelate and doxorubicin for enhancing cancer chemoimmunotherapy through synergistic effects in prostate cancer
por: Wang, Zhicheng, et al.
Publicado: (2021)

Codelivery of zoledronic acid and doublestranded RNA from core-shell nanoparticles
por: Chen, Li, et al.
Publicado: (2013)

Dopamine receptor antagonist thioridazine inhibits tumor growth in a murine breast cancer model
por: YIN, TAO, et al.
Publicado: (2015)

Codelivery of dihydroartemisinin and chlorin e6 by copolymer nanoparticles enables boosting photodynamic therapy of breast cancer with low-power irradiation
por: Jia, Jing, et al.
Publicado: (2023)

DR2 blocker thioridazine: A promising drug for ovarian cancer therapy
por: Yong, Min, et al.
Publicado: (2020)

DR2 blocker thioridazine: A promising drug for ovarian cancer therapy
por: Yong, Min, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cgoiai6clqvm1cp1ttiqa6ovp4